Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Int J Drug Policy. 2022 Nov 13;111:103906. doi: 10.1016/j.drugpo.2022.103906

Figure 2: Change in HCV-PRO Scores from the Day 0 to Week 24 Timepoint by SVR and MOUD Status.

Figure 2:

Abbreviations: SVR: sustained virologic response; MOUD: medication for opioid use disorder *p values denote the significance of the increase in HCV-PRO scores from the Day 0 to Week 24 timepoint